Lotus Pharmaceuticals, Inc.Lotus Pharmaceuticals, Inc.Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪98.75 K‬USD
‪−18.81 K‬USD
0.00USD
‪13.94 M‬
Beta (1Y)
−11.31

About Lotus Pharmaceuticals, Inc.


CEO
Georgene Rivers
Headquarters
North Port
Founded
1996
FIGI
BBG000QJ9GM0
Lotus Pharmaceuticals, Inc. engages in the manufacture and distribution of pharmaceutical products in the People's Republic of China. Its products are prescription medicines, including Valsartan, used to reduce hypertension and high blood pressure, Brimonidine Tartrate, used to constrict adrenaline receptors, Levofloxacin Lactate, an intravenous anti-bacterial drug, and Nicergoline, an anti-dementia drug. The firm also distributes products on behalf of third-party pharmaceutical manufacturers directly through its distribution network. The company was founded by Zhongyi Liu in 1996 and is headquartered in North Port, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LTUS is 0.0034 USD — it has decreased by −4.86% in the past 24 hours. Watch Lotus Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Lotus Pharmaceuticals, Inc. stocks are traded under the ticker LTUS.
LTUS stock has fallen by −9.87% compared to the previous week, the month change is a 18.10% rise, over the last year Lotus Pharmaceuticals, Inc. has showed a −37.73% decrease.
LTUS reached its all-time high on Oct 4, 2006 with the price of 8.0000 USD, and its all-time low was 0.0001 USD and was reached on Nov 7, 2013. View more price dynamics on LTUS chart.
See other stocks reaching their highest and lowest prices.
LTUS stock is 10.95% volatile and has beta coefficient of −11.31. Track Lotus Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lotus Pharmaceuticals, Inc. there?
Today Lotus Pharmaceuticals, Inc. has the market capitalization of ‪98.75 K‬, it has increased by 63.64% over the last week.
Yes, you can track Lotus Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
LTUS net income for the last quarter is ‪−2.50 K‬ USD, while the quarter before that showed ‪−5.73 K‬ USD of net income which accounts for 56.39% change. Track more Lotus Pharmaceuticals, Inc. financial stats to get the full picture.
No, LTUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LTUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lotus Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lotus Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lotus Pharmaceuticals, Inc. stock shows the sell signal. See more of Lotus Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.